A McGill University research team has developed a painless, automated way to deliver in vitro fertilization (IVF) hormones ...
- Guillaume Pfefer, Ph.D., MBA to serve as CEO; John Mendlein, Ph.D. to serve as Executive Chairman Sail unites Laronde and Senda Biosciences, two companies that deliver more than eight years of ...
Not only can these particles be transformed into tooth-cleaning shapes, but their action can have antimicrobial effects that destroy plaque-causing bacteria. Share on Facebook (opens in a new window) ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Kerry Benenato, Ph.D., has been ...
CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic ...
TEL AVIV, Israel, Oct. 10, 2023 /PRNewswire/ -- Mana.bio, a biotechnology company accelerating programmable drug delivery, today unveiled its AI-based lipid nanoparticle (LNP) delivery platform to ...
Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic DNA ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Laura Sepp-Lorenzino, Ph.D., has ...
CAMBRIDGE, Mass., Oct. 19, 2023 /PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the design and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback